Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Rhabdoid Tumor 1Pancreatic Adenocarcinoma 1Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Esophageal Neoplasms 1Endometrial Neoplasms 1Chordoma 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced Liver Cancers 1

Interventions

pembrolizumab 47Cisplatin 24Cetuximab 23Paclitaxel 18Nivolumab 18Radiotherapy 15Docetaxel 15Carboplatin 14Fluorouracil 11tremelimumab 7durvalumab 7Erlotinib Hydrochloride 6avelumab 5Radiotherapy, Intensity-Modulated 5Radiosurgery 5Pemetrexed 4Ipilimumab 4Immunoglobulin G 4Gemcitabine 4Fulvestrant 4Capecitabine 4Bevacizumab 4epacadostat 3cemiplimab 3atezolizumab 3Taxes 3Radiation 3Everolimus 3Cyclophosphamide 3Amifostine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Squamous Cell Carcinoma of Head and Neck × Tiragolumab × Clear all
NCT05459129 2025-09-15

A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)

Hoffmann-La Roche

Phase 1/2 Completed
12 enrolled 18 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡